Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based Pharmacokinetics.

Methods Mol Biol

Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Published: April 2022

Physiologically based pharmacokinetic (PBPK) modeling is a mechanistic computational model that can be used to predict a drug product's ADME (absorption, distribution, metabolism, and excretion) and pharmacokinetics (PK). In recent years, PBPK modeling and simulation has been used increasingly to address many biopharmaceutics and clinical pharmacology questions, such as the effect of formulations, intrinsic factors (age, organ dysfunction, etc.), and extrinsic factors (comedications, food) on the PK of an investigational drug product. In this chapter, we will briefly introduce various PBPK models for ADME prediction and general procedures for PBPK modeling and simulations. The readers are encouraged to read updated literature on new applications of PBPK modeling and simulation which is still an emerging area in pharmaceutical development.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-2265-0_4DOI Listing

Publication Analysis

Top Keywords

pbpk modeling
16
modeling simulation
8
pbpk
5
integration engineered
4
engineered delivery
4
delivery pharmacokinetics
4
pharmacokinetics medical
4
medical candidates
4
candidates physiology-based
4
physiology-based pharmacokinetics
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!